Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 405

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 405
---
 development expenses section, the increase in R&D costs was driven by outsourced third -partyservices for platform enhancements, and functional upgrades, as well as increased personnel expenses. However, these activities did not meet the capitalization criteria under IFRS and, in accordance with applicable accounting standards, were recorded as expenses, resulting in no capitalized intangible asset additions during the period. Net cash generated from financing activities Net cash generated from financing activities increased by $67,698, or 3.6%, from $1,867,214 for the year ended June 30, 2023, to $1,934,912 for the year ended June 30, 2024, primarily due to financing inflows from loans provided by shareholders and related parties in the year ended June 30, 2024, resulting from increased contributions by the Parent. Trend Information Please refer to “ — Key Factors Affecting Operating Results.” Off-Balance Sheet Arrangements The Company does not have any off -balancesheet arrangements. Quantitative and Qualitative Disclosures About Market Risk We are exposed to a variety of risks in the ordinary course of our business. These risks primarily include credit risk, liquidity risk and foreign currency risk. For more information about financial risks to which the Company is exposed, see note 3 to the Company’s audited combined financial statements included elsewhere in this proxy statement/prospectus. Credit Risk Credit risk refers to the risk that a counterparty will default on its contractual obligations, resulting in us incurring a financial loss. We are exposed to credit risk from its operating and financing activities, which arises principally from our accounts receivable and cash and cash equivalents. We mainly trade with recognized and creditworthy third parties. Trade receivables primarily relate to services provided to CIBIC under the commercialization agreement. Rewell customers pay in advance and therefore credit risk is mitigated. Receivable balances are monitored on an ongoing basis. As of June 30, 2024, and June 30, 2023, the Company had accounts receivable of $31,140 (of which, $18,056 from CIBIC, $4,351 from Meyer, $3,501 from Bioceres and $5,232 from others) and $308,318 (of which, $297,953 213 from CIBIC, $3,536 from Bioceres and $6,615 from others), respectively. The credit risk in respect of cash balances held with banks and deposits with banks are